State Street’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
Other funds holding CSBR
BMC
NMC
TAM
MBAM
State Street's CSBR Position: Q2 2026 in Review
State Street held its Champions Oncology (CSBR) position steady in Q2 2026 at 26,203 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3880.
State Street first reported a position in CSBR in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.15M in Q1 2021. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.
- State Street held 26,203 shares of Champions Oncology worth $161K as of Q2 2026.
- State Street left its Champions Oncology share count unchanged in Q2 2026.
- Champions Oncology made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3880 holding.
- State Street first reported a position in Champions Oncology in Q2 2020 and has held it in 25 quarters since.
- State Street's Champions Oncology position peaked at $1.15M in Q1 2021.
- 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.